EEG-based feedback, considered selectively within a fully private and multidisciplinary residential treatment plan.
Neurofeedback can appear to offer unusual precision: real-time information about brain activity and a way to practice responding differently. For someone who has tried several treatments, that promise can be compelling. Yet technology alone cannot explain a person’s difficulties, establish a diagnosis, or determine what will help.
At THE BALANCE, neurofeedback therapy may be considered as one supportive element within an assessment-led plan. It is not provided to every client, presented as a cure, or used in place of psychotherapy, psychiatric care, medical treatment, or medication. The question is whether a specific form of neurofeedback has a clear purpose for this individual and how its value will be evaluated.
Each fully private residential program and residence is dedicated to one client. Neurofeedback, when indicated and available, can therefore be scheduled around the person’s priorities, tolerance, privacy requirements, and response—not added as a standardized package.
What Is Neurofeedback Therapy?
Neurofeedback is a form of biofeedback that uses measurements of brain activity to provide information in real time. In EEG neurofeedback, sensors placed on the scalp detect electrical signals. Software processes selected features of those signals and translates them into feedback, such as a change in a sound, image, animation, or task.
The person does not interpret a medical EEG. Instead, the feedback reinforces a defined pattern through repeated practice, sometimes described as learning to self-regulate aspects of brain activity. This is connected with neuroplasticity: the brain’s capacity to adapt through experience and repetition.
Neurofeedback is not the same as transcranial magnetic stimulation, transcranial direct-current stimulation, or electroconvulsive therapy. Those methods use external stimulation. Standard EEG neurofeedback measures activity and returns information about it. Protocols and professional requirements vary, so “neurofeedback” does not describe one uniform treatment.
How Does EEG Neurofeedback Work?
A neurofeedback process generally includes four elements:
- Assessment and a defined target. The responsible professional identifies the clinical or functional question the training is intended to address.
- Measurement. Sensors record EEG activity from selected scalp locations. EEG or quantitative EEG may contribute information, but an EEG pattern is not a stand-alone psychiatric diagnosis.
- Real-time feedback. Software analyzes selected features of the signal. When the chosen parameters move in the intended direction, the client receives an immediate visual or auditory response.
- Review and adaptation. The provider considers tolerance and whether change is meaningful outside the session. The protocol may be continued, adjusted, paused, or stopped.
The client may watch a screen, listen to tones, or complete a simple task. No sensor penetrates the skin. Sessions are usually physically undemanding, although concentration, sensory input, or changes in arousal may feel tiring.
What Neurofeedback May Be Intended to Support
Research has examined neurofeedback in relation to attention-deficit/hyperactivity disorder, post-traumatic stress disorder, depression, anxiety, sleep disturbance, substance-use disorders, chronic pain, migraine, epilepsy, and other neurological or psychological concerns. The existence of research does not mean that benefit is established equally across these uses.
At THE BALANCE, neurofeedback is not selected from a diagnosis alone. It must have a defined role within the client’s working formulation. The intended target might relate to attention, arousal, sleep, emotional regulation, stress reactivity, or engagement in therapy. These are goals, not guaranteed outcomes.
Distress should not be reduced to a defective brainwave pattern. Mental health, trauma, sleep, physical health, medication, relationships, behavior, and environment may interact. A sophisticated intervention can still be irrelevant if disconnected from that wider picture.
What Does the Evidence Say?
The evidence for neurofeedback is developing but uneven. Studies use different technologies, targets, schedules, comparison groups, and outcomes. Some report improvements; others find inconsistent effects or results that are difficult to separate from nonspecific treatment factors.
Research in PTSD and depression has produced promising findings, but small studies, diverse protocols, and methodological limitations restrict generalization. A large 2025 review of adult ADHD treatments found inconsistent effects for nonpharmacological approaches across raters; the neurostimulation and neurofeedback evidence involved relatively few participants. Researchers have developed reporting and design standards to improve reliability.
The protocol, indication, evidence, alternatives, and method of measuring progress all matter. THE BALANCE does not publish a universal success rate because no responsible figure applies across different people, conditions, protocols, and definitions of improvement.
Neurofeedback Within the Balance Model
Neurofeedback is considered within Assessment and Treatment Planning and the Multidisciplinary Clinical Model. A psychiatrist, psychologist, physician, therapist, or other relevant professional may contribute to the decision, while one clinical direction connects the intervention with the broader plan.
Where neurofeedback has a defined purpose, it may be coordinated alongside:
- psychotherapy and trauma-focused work;
- psychiatric review and medication management;
- medical or neurological assessment where indicated;
- sleep, nutrition, movement, somatic, and regulation-focused support;
- family work and preparation for continuing care.
The goal is to determine whether neurofeedback helps the client engage in the work that matters. If it adds burden, causes adverse effects, produces no meaningful change, or distracts from a higher priority, it is reconsidered.
Assessment, Suitability, and Clinical Oversight
Before neurofeedback begins, the team considers the presenting concern, psychiatric and medical history, medication, sleep, substance use or withdrawal, neurological conditions, seizure history, sensory sensitivity, current stability, and ability to report changes.
The proposal should explain:
- why neurofeedback is being considered;
- the specific goal and protocol;
- who is qualified and responsible for providing it;
- where sessions will take place;
- the expected course and review point;
- known limitations, possible adverse effects, and alternatives;
- how benefit or lack of benefit will be assessed;
- when the intervention would be adjusted or stopped.
A quantitative EEG, when used, is one source of information. It does not replace clinical assessment, established diagnostic methods, or review of daily functioning. Technical data should clarify decisions, not create unsupported certainty.
Safety and Possible Side Effects
EEG neurofeedback is noninvasive, but adverse effects can occur. Reported experiences include fatigue, headache, dizziness, temporary difficulty concentrating, sleep changes, anxiety or agitation, low mood, and overstimulation. Effects may relate to the protocol, the person’s history, medication, sleep, withdrawal, or another condition.
A person with a neurological condition, seizure history, marked mood instability, acute psychiatric symptoms, or significant medical complexity may require additional assessment or a different pathway. An urgent change follows the appropriate clinical or emergency process, not routine training management.
Medication should not be reduced or stopped without the responsible prescriber’s guidance. A client can decline neurofeedback without making the wider plan incomplete.
How Progress Is Evaluated
A device display is not enough. The team defines what a meaningful result would look like in the client’s life, such as sleep consistency, concentration, recovery after stress, participation in therapy, daily functioning, or a validated symptom measure.
Progress is reviewed through the client’s experience, daily observations, appropriate measures, and discussion among relevant professionals. Changes in mood, energy, sleep, attention, or physical symptoms are interpreted in context because several elements of treatment may change together.
There is no universal number of sessions. THE BALANCE defines an initial course and an early review point rather than promising that a fixed schedule will produce a result. Completing a package is not more important than clinical judgment.
Fully Private Care in Mallorca and Zurich
THE BALANCE provides private residential treatment in Mallorca and Zurich, with each program and residence dedicated to one client. Neurofeedback may be considered within either pathway only when clinically appropriate, currently available, and supported by a suitably qualified provider.
Some services may be residence-linked; others may require an independent clinic. The proposal states the provider, location, responsibilities, consent process, privacy arrangements, and any separate fees. Website copy does not confirm availability.
For executives, public figures, internationally mobile families, and HNWI or UHNWI clients, privacy may determine whether treatment feels possible. The one-client model allows access, transport, scheduling, and authorized communication to be planned discreetly. Privacy supports care; it does not alter clinical standards.
Preparing for Continuing Care
The longer-term goal is not dependence on a device. If neurofeedback appears useful, any improvement should be connected to daily routines, sleep, relationships, work, decision-making, psychotherapy, and the environment to which the client will return.
Some clients may continue with a qualified provider after residential treatment; others may complete a defined course or stop. Continuation depends on clinical indication, lawful provision, provider competence, access, and evidence of benefit. Handover requires appropriate authorization.
